Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04585269 · ClinicalTrials.gov registry record · NA

Bright IDEAS - Young Adults Problem-Solving Skills Training

A NA study of Cancer Patients and Supportive Care, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
344
Enrollment target
3
Study locations

NCT04585269: Active NA study of Cancer Patients and Supportive Care, sponsored by Rutgers, The State University of New Jersey.

NCT04585269 is a NA study of Cancer Patients and Supportive Care that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 344 participants, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (71% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04585269, a NA study of Cancer Patients and Supportive Care, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
344 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this project is to evaluate efficacy of Bright IDEAS, an evidence-based problem-solving skills training (PSST) program, as a supportive care intervention for young adult (YA) cancer patients compared with enhanced usual psychosocial care with 344 young adult patients newly diagnosed with cancer.

Primary Outcome

Respondents report symptoms on a 5-point rating scale from 1 "never" to 5 "always" in the past 7 days, with higher scores indicating higher levels of negative affect. A total raw summary score is calculated and then translated into a standardized T-score with a mean of 50 and standard deviation of 10, with higher scores indicating higher symptoms. The change in T-score points from baseline to 6 months will be examined, with positive scores indicating increasing symptoms and negative scores indic

Interventions

  • BEHAVIORAL Bright IDEAS-YA

Study Locations (3)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

New Jersey

  • Rutgers Cancer Institute of New Jersey - New Brunswick

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2021-02-10
Est. Completion 2026-04
Phase NA

What the registry record for NCT04585269 still lists

NCT04585269 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (71% higher).

The record links to 3 conditions, with Cancer Patients appearing as the primary indexed condition, and to 1 intervention - of which Bright IDEAS-YA is the first listed.

NCT04585269 reports a single indexed study location in Florida, New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT04585269 about?

NCT04585269 is a clinical study titled "Bright IDEAS - Young Adults Problem-Solving Skills Training". The purpose of this project is to evaluate efficacy of Bright IDEAS, an evidence-based problem-solving skills training (PSST) program, as a supportive care intervention for young adult (YA) cancer patients compared with enhanced usual psychosocial care with 344 young adult patients newly diagnosed w...

What is the current status of trial NCT04585269?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2021-02-10. Estimated completion is 2026-04.

What conditions does trial NCT04585269 study?

This clinical trial studies the following conditions: Cancer Patients, Supportive Care, Young Adult.

What interventions are being tested in trial NCT04585269?

The interventions under investigation include: Bright IDEAS-YA (BEHAVIORAL).

Who is sponsoring clinical trial NCT04585269?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04585269 being conducted?

This trial has 3 study locations across Florida, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Patients

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04585269's enrollment target sits among peer trials

344 4th of 8 higher than 5 of 8 other Cancer Patients trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer Patients trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06733363 · 344 participants · Phase 2

    A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

  • NCT07179380 · 344 participants · Phase 3

    Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NCT07304024 · 344 participants · Phase 1

    A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04585269, the US trial registry maintained by the National Library of Medicine. NCT04585269 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.